FDA Inspection 1260496 — Vitalant

Vitalant — FEI 1671451

The FDA completed an inspection of Vitalant on Jan 23, 2025 in El Paso, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 23, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
El Paso, TX (United States)